首页/数据集/Clinical and demographic details of patients and healthy controls.

Clinical and demographic details of patients and healthy controls.

NIAID Data Ecosystem2026-03-07 收录

数据链接：

https://figshare.com/articles/dataset/_Clinical_and_demographic_details_of_patients_and_healthy_controls_/404913 数据链接链接失效反馈

官方服务：

资源简介：

†Copaxone®; ‡Avonex® n = 5, Betaferon® n = 5, Rebif® 22 n = 4, Rebif® 44 n = 8; SD: standard deviation.

应用场景：

创建时间：

2011-09-16

多发性硬化症临床研究

治疗成本分析

Summary of TC for patients with multiple sclerosis (study purpose, study design, place of study, sample size (attribution%), age of patients, disease duration, and stage in disease progression.

NIAID Data Ecosystem60

Descriptive statistics of the cohort.

多发性硬化症临床研究

运动功能评估

Data as median, range in square brackets, lower/upper quartiles in round brackets, RRMS = Relapsing-remitting MS, SPMS = secondary progressive MS, PPMS = primary progressive MS, 6MWT = 6 Minute Walkin

Figshare2015-12-03 更新20

Motor and respiratory functions are main challenges to patients with multiple sclerosis

神经功能评估

多发性硬化症临床研究

Abstract Introduction People with multiple sclerosis (MS) present wide and varied symptoms. Objective To investigate the impact of MS on subjects’ motor and respiratory functions. Methods One hundred

Figshare2023-01-01 更新10

Full dataset of relapsing-remitting MS patients (N = 145).

多发性硬化症临床研究

疾病修饰疗法疗效评估

DMD, disease-modifying drug; EDSS, expanded disability status scale; IT, immunotherapy; MS, multiple sclerosis; N, number of patients; OTC, over-the-counter; PRN, pro re nata. (XLSX)

NIAID Data Ecosystem30

MS LCL Short Read 1

多发性硬化症临床研究

疾病状态分析

Sample ID Group Disease Activity Age Sex Race Note HC1 Heatlhy Control NA 65 M WC HC2 Heatlhy Control NA 58 M Asian HC3 Heatlhy Control NA 73 F WC S2 MS Stable 43 F WC same patient as A

Zenodo2025-10-07 更新10

Clinical and demographic details of patients and healthy controls.

资源简介：

相关数据集